Multifaceted Roles of Copper Ions in Anticancer Nanomedicine

被引:30
作者
Yang, Siyuan [1 ]
Song, Yingnan [1 ,3 ]
Hu, Yanling [2 ]
Chen, HongJin [1 ,3 ]
Yang, Dongliang [4 ]
Song, Xuejiao [4 ]
机构
[1] Guizhou Med Univ, Guizhou Inst Precis Med, Dept Cardiac Surg, Affiliated Hosp, Guiyang 550009, Guizhou, Peoples R China
[2] Nanjing Polytech Inst, Nanjing 210048, Peoples R China
[3] Guizhou Med Univ, Translat Med Res Ctr, Guiyang 550025, Guizhou, Peoples R China
[4] Nanjing Tech Univ NanjingTech, Sch Phys & Math Sci, 30 South Puzhu Rd, Nanjing 211816, Peoples R China
关键词
copper ions; nanomedicines; tumor microenvironments; tumor therapy; ENHANCED CHEMODYNAMIC THERAPY; CYTOCHROME-C-OXIDASE; TUMOR MICROENVIRONMENT; SONODYNAMIC THERAPY; D-PENICILLAMINE; CANCER-THERAPY; DRUG-DELIVERY; CELL-DEATH; PHASE-II; NANOPARTICLES;
D O I
10.1002/adhm.202300410
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The significantly increased copper level in tumor tissues and serum indicates the close association of copper ions with tumor development, making copper ions attractive targets in the development of novel tumor treatment methods. The advanced nanotechnology developed in the past decades provides great potential for tumor therapy, among which Cu-based nanotherapeutic systems have received greater attention. Here, the multifaceted roles of copper ions in cancer progression are summarized and the recent advances in the copper-based nanostructures or nanomedicines for different kinds of tumor therapies including copper depletion therapy, copper-based cytotoxins, copper-ion-based chemodynamic therapy and its combination with other treatments, and copper-ion-induced ferroptosis and cuproptosis activation are discussed. Furthermore, the perspectives for the further development of copper-ion-based nanomedicines for tumor therapy and clinic translation are presented by the authors.
引用
收藏
页数:23
相关论文
共 160 条
  • [1] Copper depletion increases the mitochondrial-associated SOD1 in neuronal cells
    Arciello, Mario
    Capo, Concetta Rosa
    D'Annibale, Sara
    Cozzolino, Mauro
    Ferri, Alberto
    Carri, Maria Teresa
    Rossi, Luisa
    [J]. BIOMETALS, 2011, 24 (02) : 269 - 278
  • [2] Platinum drugs, copper transporters and copper chelators
    Arnesano, Fabio
    Nardella, Maria I.
    Natile, Giovanni
    [J]. COORDINATION CHEMISTRY REVIEWS, 2018, 374 : 254 - 260
  • [3] Natural killer cells induce distinct modes of cancer cell death: Discrimination, quantification, and modulation of apoptosis, necrosis, and mixed forms
    Backes, Christian S.
    Friedmann, Kim S.
    Mang, Sebastian
    Knoerck, Arne
    Hoth, Markus
    Kummerow, Carsten
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (42) : 16348 - 16363
  • [4] The tumor microenvironment at a glance
    Balkwill, Frances R.
    Capasso, Melania
    Hagemann, Thorsten
    [J]. JOURNAL OF CELL SCIENCE, 2012, 125 (23) : 5591 - 5596
  • [5] Dendrimers in drug research
    Boas, U
    Heegaard, PMH
    [J]. CHEMICAL SOCIETY REVIEWS, 2004, 33 (01) : 43 - 63
  • [6] Apoptosis, cancer and cancer therapy
    Bold, RJ
    Termuhlen, PM
    McConkey, DJ
    [J]. SURGICAL ONCOLOGY-OXFORD, 1997, 6 (03): : 133 - 142
  • [7] Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma
    Brem, S
    Grossman, SA
    Carson, KA
    New, P
    Phuphanich, S
    Alavi, JB
    Mikkelsen, T
    Fisher, JD
    [J]. NEURO-ONCOLOGY, 2005, 7 (03) : 246 - 253
  • [8] The use of copper-lowering therapy with tetrathiomolybdate in medicine
    Brewer, George J.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (01) : 89 - 97
  • [9] Copper control as an antiangiogenic anticancer therapy: Lessons from treating Wilson's disease
    Brewer, GJ
    [J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2001, 226 (07) : 665 - 673
  • [10] Nanoparticles in cancer therapy and diagnosis
    Brigger, I
    Dubernet, C
    Couvreur, P
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (05) : 631 - 651